China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
National Health Commission of the People’s Republic of China [to 4 Dec 2021]
Dec 4: Daily briefing on novel coronavirus cases in China
On Dec 3, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 90 new cases of confirmed infections.
China has provided over 1.8b COVID-19 vaccine doses to international community
BEIJING – To date, China has provided over 1.8 billion doses of COVID-19 vaccines to more than 120 countries and international organizations.
China has delivered on its promise to make vaccines global public goods, and made continued efforts to improve vaccine accessibility and affordability in developing countries.
China has pledged to strive to provide a total of 2 billion vaccine doses to the world by the end of this year, and said that in addition to donating $100 million to COVAX, it would donate 100 million vaccine doses to other developing countries in the course of this year.
As of Nov 12, China has supplied more than 70 million vaccine doses to COVAX and is conducting joint vaccine production with 19 developing countries…
China pushing development of vaccine against Omicron
China is rapidly advancing development of COVID-19 vaccines targeting the Omicron variant, a health official said during an interview with China Central Television on Thursday.
Zheng Zhongwei, a National Health Commission official who heads China’s COVID-19 vaccine development task force, said preliminary analysis suggests that the new strain is more transmissible than the Delta variant, but it is too early to determine if the Omicron variant would diminish the efficacy of existing vaccines.
“We think the majority of vaccines remain effective,” he said. “Despite the possibility of some degree of immunity escape, our initial finding is that they still have marked effects on preventing severe diseases and deaths.”…
China sticks to its strategy in COVID-19 response: official
BEIJING — A health official has emphasized the importance of committing to the current strategy in China to clear COVID-19 infections in a timely manner as highly contagious variants of the virus continue to rage around the world.
Since mid-October, the latest COVID-19 resurgence in China has spread to more than 20 provincial-level regions. Most regions managed to contain the outbreak within an incubation period of about 14 days, said Ma Xiaowei, head of the National Health Commission, in a recent interview with Xinhua.
“We have been thinking, especially during the process of coping with the spread of the Delta variant, how to control the epidemic with more effective measures, lower costs and at faster speeds to minimize its impact on economic and social development and people’s lives,” Ma said.
He added that the government has also noticed that the epidemic response in some countries, which have not implemented strict epidemic control measures, has not been satisfactory. There have been relapses that severely impacted people’s lives, health and the economy and society overall.
As a result, China has been focusing on improving epidemic prevention and early detection, he noted…